Prolactinoma
Endocrine glands release hormones (chemical messengers) into the bloodstream to be transported to various organs and tissues throughout the body. For instance, the pancreas secretes insulin, which allows the body to regulate levels of sugar in the blood. The thyroid gets instructions from the pituitary to secrete hormones which determine the pace of chemical activity in the body (the more hormone in the bloodstream, the faster the chemical activity; the less hormone, the slower the activity).
Also known as: Prolactinoma - females, Adenoma - secreting or Prolactin-secreting adenoma of the pituitary
- Abnormal milk flow from the breast in a woman who is not pregnant or nursing (galactorrhea)
- Breast tenderness
- Decreased sexual interest
- Headache
- Infertility
- Stopping of menstruation not related to menopause
- Vision changes
- Decreased sexual interest
- Enlargement of breast tissue (gynecomastia)
- Headache
- Impotence
- Infertility
- Vision changes
- Headache
- Lethargy
- Nasal drainage
- Nausea and vomiting
- Problems with the sense of smell
- Vision changes
- Double vision
- Drooping eyelids
- Visual field loss
- Cranial MRI or cranial CT scan showing a pituitary mass
- Decreased testosterone levels in men
- Prolactin levels
- Infertility
- Irregular menstruation
- Loss of sexual interest
- Milk flow not related to childbirth or nursing
- Decreased sexual drive
- Impotence
- Infertility
- Bleeding
- Tumor regrowth
- Blindness
- Double vision
- Permanent vision loss
Definition
A prolactinoma is a noncancerous pituitary tumor that produces a hormone called prolactin. This results in too much prolactin in the blood.
Causes, incidence, and risk factors
Prolactin is a hormone that triggers the breasts to produce milk (lactation).
Prolactinoma is the most common type of pituitary tumor (adenoma). It makes up at least 30% of all pituitary adenomas. Most pituitary tumors are noncancerous (benign). Prolactinoma may occur as part of a hereditary disorder called multiple endocrine neoplasia type 1 (MEN 1)
Prolactinomas occur most commonly in people under age 40. They are about five times more common in women than men, but are rare in children.
At least half of all prolactinomas are very small (less than 1 cm or 3/8 of an inch in diameter). These microprolactinomas are more common in women. Many small tumors remain small and never get larger.
Larger tumors, called macroprolactinomas, are more common in men. Prolactinomas in men tend to occur at an older age and can grow to a large size before any symptoms appear.
Symptoms
In women:
In men:
Symptoms caused by pressure from a larger tumor may include:
Note: There may be no symptoms, particularly in men.
Signs and tests
Treatment
Not everyone needs treatment for prolactinoma.
Medication is usually successful in treating prolactinoma. Surgery is done in some cases where the tumor may damage vision.
In women, treatment can improve:
Men should be treated when they have:
Large prolactinomas generally must be treated to prevent vision loss.
Bromocriptine and cabergoline are drugs that reduce prolactin levels in both men and women. They usually must be taken for life. If the drug is stopped, the tumor may grow and produce prolactin again, especially if it is a large tumor. Most people respond well to these drugs, although large prolactinomas are more difficult to treat. Both drugs may cause dizziness and upset stomach.
Using bromocriptine over time can reduce the chance of being cured by removing the tumor. Therefore, if surgery is needed, it is best to remove the tumor during the first 6 months of using this drug.
Radiotherapy with conventional radiation or gamma knife is usually reserved for patients with prolactinoma that continues or gets worse after both medication and surgery.
Expectations (prognosis)
The outlook depends on the success of medical therapy or surgery. Tests to check whether the tumor has returned after treatment are important.
Complications
If untreated, a growing tumor can press on the optic nerves and cause:
Calling your health care provider
See your health care provider if you have any symptoms of prolactinoma.
If you have had a prolactinoma in the past, call your health care provider if the symptoms return.
References
Melmed S, Kleinberg D. Anterior pituitary. In: Kronenberg HM, Melmed S, Polonsky KS, Larsen PR, eds. Williams Textbook of Endocrinology. Philadelphia, PA: Saunders Elsevier; 2008:chap 8.
- Review date:
- November 23, 2009
- Reviewed by:
- Ari S. Eckman, MD, Division of Endocrinology and Metabolism, Johns Hopkins School of Medicine, Baltimore, MD. Review provided by VeriMed Healthcare Network. Also reviewed by David Zieve, MD, MHA, Medical Director, A.D.A.M., Inc.
Copyright Information
A.D.A.M., Inc. is accredited by URAC, also known as the American Accreditation HealthCare Commission (www.urac.org). URAC's accreditation program is an independent audit to verify that A.D.A.M. follows rigorous standards of quality and accountability. A.D.A.M. is among the first to achieve this important distinction for online health information and services. Learn more about A.D.A.M.'s editorial policy, editorial process and privacy policy. A.D.A.M. is also a founding member of Hi-Ethics and subscribes to the principles of the Health on the Net Foundation (www.hon.ch).The information provided herein should not be used during any medical emergency or for the diagnosis or treatment of any medical condition. A licensed medical professional should be consulted for diagnosis and treatment of any and all medical conditions. Call 911 for all medical emergencies. Links to other sites are provided for information only -- they do not constitute endorsements of those other sites. © 1997- 2008 A.D.A.M., Inc. Any duplication or distribution of the information contained herein is strictly prohibited.